In contrast, males demonstrated a more pronounced response to BC supplementation, with marked increases in hepatic expressions of BC cleavage enzymes (Bco1 and Bco2) and BC mobilization markers (Rbp4 and Stra6l), despite having lower baseline levels than females. Here, RBP4 is linked to breast cancer.